CoChat

Biofilm and Small Colony Variants—An Update on Staphylococcus aureus Strategies toward Drug Resistance

Guo, Henan, Tong, Yucui, Cheng, Junhao, Abbas, Zaheer, Li, Zhongxuan, Wang, Junyong, Zhou, Yichen, Si, Dayong, Zhang, Rijun · 2022 · International Journal of Molecular Sciences
Cited by 120

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Recently, the drawbacks arising from the overuse of antibiotics have drawn growing public attention. Among them, drug-resistance (DR) and even multidrug-resistance (MDR) pose significant challenges in clinical practice. As a representative of a DR or MDR pathogen, Staphylococcus aureus can cause diversity of infections related to different organs, and can survive or adapt to the diverse hostile environments by switching into other phenotypes, including biofilm and small colony variants (SCVs), with altered physiologic or metabolic characteristics. In this review, we briefly describe the development of the DR/MDR as well as the classical mechanisms (accumulation of the resistant genes). Moreover, we use multidimensional scaling analysis to evaluate the MDR relevant hotspots in the recent published reports. Furthermore, we mainly focus on the possible non-classical resistance mechanisms triggered by the two important alternative phenotypes of the S. aureus, biofilm and SCVs, which are fundamentally caused by the different global regulation of the S. aureus population, such as the main quorum-sensing (QS) and agr system and its coordinated regulated factors, such as the SarA family proteins and the alternative sigma factor σB (SigB). Both the biofilm and the SCVs are able to escape from the host immune response, and resist the therapeutic effects of antibiotics through the physical or the biological barriers, and become less sensitive to some antibiotics by the dormant state with the limited metabolisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23031241

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 149

  1. Price, N., and Klein, J.L. (2016). Infectious Diseases, Oxford University Press (OUP). · doi:10.1093/med/9780199565979.003.0006
  2. Zohra, T., Numan, M., Ikram, A., Salman, M., Khan, T., Din, M., Salman, M., Farooq, A., Amir, A., and Ali, M. (2021). Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and other Strategies in ESKAPE Pathogens. Microorganisms, 9. · DOI
  3. Levy, 2004, Antibacterial resistance worldwide: Causes, challenges and responses, Nat. Med., 10, S122, 10.1038/nm1145 · DOI · Paper page
  4. Rice, 2010, Progress and Challenges in Implementing the Research on ESKAPE Pathogens, Infect. Control Hosp. Epidemiol., 31, S7, 10.1086/655995 · DOI · Paper page
  5. Kahl, 2016, Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persis-tent Infections, Clin. Microbiol. Rev., 29, 401, 10.1128/CMR.00069-15 · DOI · Paper page
  6. Bui, 2017, Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus, Essays Biochem., 61, 71, 10.1042/EBC20160061 · DOI
  7. Boles, 2004, Self-generated diversity produces “insurance effects” in biofilm communities, Proc. Natl. Acad. Sci. USA, 101, 16630, 10.1073/pnas.0407460101 · DOI · Paper page
  8. Tuchscherr, L., Geraci, J., and Löffler, B. (2017). Staphylococcus aureus Regulator Sigma B is Important to Develop Chronic Infections in Hematogenous Murine Osteomyelitis Model. Pathogens, 6. · DOI
  9. Tuchscherr, 2016, Staphylococcus aureus Dynamically Adapts Global Regulators and Virulence Factor Expression in the Course from Acute to Chronic Infection, Curr. Genet., 62, 15, 10.1007/s00294-015-0503-0 · DOI
  10. Tan, 2014, Small-Colony Variants and Phenotype Switching of Intracellular Staphylococcus aureus in Chronic Rhinosinusitis, Allergy, 69, 1364, 10.1111/all.12457 · DOI
  11. Mbbs, 2020, Staphylococcus aureus biofilm exoproteins are cytotoxic to human nasal epithelial barrier in chronic rhinosinusitis, Int. Forum Allergy Rhinol., 10, 871, 10.1002/alr.22566 · DOI
  12. Xiao, 2019, Community-Associated Staphylococcus aureus PVL+ ST22 predominates in skin and soft tissue infections in Beijing, China, Infect. Drug Resist., 12, 2495, 10.2147/IDR.S212358 · DOI
  13. Besier, 2008, Thymidine-Dependent Staphylococcus aureus Small-Colony Variants: Human Pathogens That Are Relevant Not Only in Cases of Cystic Fibrosis Lung Disease, J. Clin. Microbiol., 46, 3829, 10.1128/JCM.01440-08 · DOI · Paper page
  14. Bates, 2003, Staphylococcus aureus men D and hemB Mutants are as Infective as the Parent Strains, but the Menadione Biosynthetic Mutant Persists within the Kidney, J. Infect. Dis., 187, 1654, 10.1086/374642 · DOI · Paper page
  15. Herrmann, 2014, Antimicrobial Effects Promoting Biofilm Formation and Persistent Disease: The Role of a DNA-Binding Regu-lator, SarA, in Staphylococcal endocarditis, J. Infect. Dis., 209, 1153, 10.1093/infdis/jiu008 · DOI
  16. Tuchscherr, L., Pöllath, C., Siegmund, A., Deinhardt-Emmer, S., Hoerr, V., Svensson, C.-M., Figge, M.T., Monecke, S., and Löffler, B. (2019). Clinical, S. aureus Isolates Vary in Their Virulence to Promote Adaptation to the Host. Toxins, 11. · DOI · Paper page
  17. Rom, 2021, Limiting protease production plays a key role in the pathogenesis of the divergent clinical isolates of Staphylococcus aureus LAC and UAMS-1, Virulence, 12, 584, 10.1080/21505594.2021.1879550 · DOI
  18. Spanu, 2005, Recurrent Ventriculoperitoneal Shunt Infection Caused by Small-Colony Variants of Staphylococcus aureus, Clin. Infect. Dis., 41, e48, 10.1086/432577 · DOI · Paper page
  19. Huang, 2021, The cytoplasmic loops of AgrC contribute to the quorum-sensing activity of Staphylococcus aureus, J. Microbiol., 59, 92, 10.1007/s12275-021-0274-x · DOI
  20. Cong, 2020, Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features, J. Adv. Res., 21, 169, 10.1016/j.jare.2019.10.005 · DOI · Paper page
  21. Kirby, 1944, Extraction of a Highly Potent Penicillin Inactivator from Penicillin Resistant Staphylococci, Science, 99, 452, 10.1126/science.99.2579.452 · DOI · Paper page
  22. Rountree, 1955, Infections caused by a particular phage type of Staphylococcus aureus, Med. J. Aust., 42, 157, 10.5694/j.1326-5377.1955.tb35001.x · DOI
  23. Barber, 1961, Methicillin-Resistant Staphylococci, J. Clin. Pathol., 14, 385, 10.1136/jcp.14.4.385 · DOI · Paper page
  24. Jevons, 1961, Celbenin-Resistant Staphylococci, Brit. Med. J., 2, 939
  25. Weigel, 2003, Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus, Science, 302, 1569, 10.1126/science.1090956 · DOI · Paper page
  26. Dunn, 2019, The Evolution and Transmission of Multi-Drug Resistant Escherichia coil and Klebsiella Pneumoniae: The Complexity of Clones and Plasmids, Curr. Opin. Microbiol., 51, 51, 10.1016/j.mib.2019.06.004 · DOI · Paper page
  27. Munk, 2018, Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countries, Nat. Microbiol., 3, 898, 10.1038/s41564-018-0192-9 · DOI · Paper page
  28. Sun, 2020, Environmental Remodeling of Human Gut Microbiota and Antibiotic Resistome in Livestock Farms, Nat. Commun., 11, 1427, 10.1038/s41467-020-15222-y · DOI · Paper page
  29. Danner, 2019, Antibiotic pollution in surface fresh waters: Occurrence and effects, Sci. Total Environ., 664, 793, 10.1016/j.scitotenv.2019.01.406 · DOI · Paper page
  30. Naskar, A., and Kim, K.-S. (2019). Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations. Microorganisms, 7. · DOI · Paper page
  31. Kumar, 2015, Defining multidrug resistance in Gram-negative bacilli, Indian J. Med. Res., 141, 491, 10.4103/0971-5916.159318 · DOI
  32. Cassini, 2019, At-tributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis, Lancet Infect. Dis., 19, 56, 10.1016/S1473-3099(18)30605-4 · DOI · Paper page
  33. Stewardson, 2019, Effect of Carbapenem Resistance on Outcomes of Bloodstream Infection Caused by Enterobacteriaceae in Low-Income and Middle-Income Countries (PANORAMA): A Multinational Prospective Co-hort Study, Lancet Infect. Dis., 19, 601, 10.1016/S1473-3099(18)30792-8 · DOI · Paper page
  34. Gandra, 2019, The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study, Clin. Infect. Dis., 69, 563, 10.1093/cid/ciy955 · DOI · Paper page
  35. Wang, 2019, Small RNA AvrA Regulates IscR to Increase the Stress Tolerances in SmpB Deficiency of Aeromonas veronii, Front Cell Infect Mi., 9, 142, 10.3389/fcimb.2019.00142 · DOI
  36. Liu, 2012, A Study on Mining Bibliographic Records by Designed Software SATI: Case Study on Library and Information Science, J. Inf. Resour. Manag., 2, 50
  37. Lee, 2020, Novel Research Models for Staphylococcus aureus Small Colony Variants (SCV) Development: Co-pathogenesis and Growth Rate, Front. Microbiol., 11, 321, 10.3389/fmicb.2020.00321 · DOI · Paper page
  38. Fraunholz, 2012, Intracellular Staphylococcus aureus: Live-in and let die, Front. Cell. Infect. Microbiol., 2, 43, 10.3389/fcimb.2012.00043 · DOI · Paper page
  39. Strobel, 2016, Post-invasion events after infection with Staphylococcus aureus are strongly dependent on both the host cell type and the infecting S. aureus strain, Clin. Microbiol. Infect., 22, 799, 10.1016/j.cmi.2016.06.020 · DOI · Paper page
  40. Haunreiter, 2020, Intracellular Environment and agr System Affect Colony Size Heterogeneity of Staphylococcus aureus, Front. Microbiol., 11, 1415, 10.3389/fmicb.2020.01415 · DOI
  41. Wood, 2013, Bacterial Persister Cell Formation and Dormancy, Appl. Environ. Microbiol., 79, 7116, 10.1128/AEM.02636-13 · DOI · Paper page
  42. Keren, 2004, Persister cells and tolerance to antimicrobials, FEMS Microbiol. Lett., 230, 13, 10.1016/S0378-1097(03)00856-5 · DOI · Paper page
  43. Singh, 2009, Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: An in vitro study, J. Med. Microbiol., 58, 1067, 10.1099/jmm.0.009720-0 · DOI · Paper page
  44. Chen, 2011, The role of bacterial biofilm in persistent infections and control strategies, Int. J. Oral Sci., 3, 66, 10.4248/IJOS11022 · DOI · Paper page
  45. Craft, 2019, Methicillin-Resistant Staphylococcus aureus (MRSA): Antibiotic-Resistance and the Biofilm Phenotype, Medchemcomm, 1, 1231, 10.1039/C9MD00044E · DOI · Paper page
  46. Schilcher, 2020, Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies, Microbiol. Mol. Biol. Rev., 84, e00026-19, 10.1128/MMBR.00026-19 · DOI · Paper page
  47. Landini, 2010, Molecular Mechanisms of Compounds Affecting Bacterial Biofilm For-mation and Dispersal, Appl. Microbiol. Biot., 86, 813, 10.1007/s00253-010-2468-8 · DOI · Paper page
  48. Kohler, 2008, A Defect in Menadione Biosynthesis Induces Global Changes in Gene Expression in Staphylococcus aureus, J. Bacteriol., 190, 6351, 10.1128/JB.00505-08 · DOI · Paper page
  49. Idrees, M., Sawant, S., Karodia, N., and Rahman, A. (2021). Staphylococcus aureus Biofilm: Morphology, Genetics, Pathogenesis and Treatment Strategies. Int. J. Environ. Res. Public Health, 18. · DOI · Paper page
  50. Reffuveille, F., Josse, J., Vallé, Q., Gangloff, C.M., and Gangloff, S.C. (2017). Staphylococcus aureus Biofilms and Their Impact on the Medical Field. The Rise of Virulence and Antibiotic Resistance in Staphylococcus aureus, InTech. · DOI
  51. Nguyen, 2020, The Staphylococcal Exopolysaccharide PIA—Biosynthesis and Role in Biofilm Formation, Colonization, and Infection, Comput. Struct. Biotec., 18, 3324, 10.1016/j.csbj.2020.10.027 · DOI · Paper page
  52. Corrigan, 2007, The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation, Microbiology, 153, 2435, 10.1099/mic.0.2007/006676-0 · DOI · Paper page
  53. Hauck, 2006, Sticky Connections: Extracellular Matrix Protein Recognition and Integrin-Mediated Cellular Invasion by Staphylococcus aureus Christof R Hauck and Knut Ohlsen, Curr. Opin. Microbiol., 9, 5, 10.1016/j.mib.2005.12.002 · DOI · Paper page
  54. Foster, 2014, Adhesion, invasion and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  55. Idrees, M., Mohammad, A.R., Karodia, N., and Rahman, A. (2020). Multimodal Role of Amino Acids in Microbial Control and Drug Development. Antibiotics, 9. · DOI
  56. Taglialegna, 2016, Amyloid Structures as Biofilm Matrix Scaffolds, J. Bacteriol., 198, 2579, 10.1128/JB.00122-16 · DOI · Paper page
  57. Miao, 2019, Biofilm Formation of Staphylococcus aureus under Food Heat Processing Conditions: First Report on CML Production within Biofilm, Sci. Rep., 9, 1312, 10.1038/s41598-018-35558-2 · DOI
  58. Kong, 2006, Staphylococcus quorum sensing in biofilm formation and infection, Int. J. Med. Microbiol., 296, 133, 10.1016/j.ijmm.2006.01.042 · DOI · Paper page
  59. Lu, 2019, Developing Natural Products as Potential Anti-Biofilm Agents, Chin. Med. UK, 14, 11, 10.1186/s13020-019-0232-2 · DOI · Paper page
  60. Dunman, 2001, Transcription Profiling-Based Identification of Staphylococcus aureus Genes Regulated by the agr and/or sarA Loci, J. Bacteriol., 183, 7341, 10.1128/JB.183.24.7341-7353.2001 · DOI · Paper page
  61. Harraghy, 2006, Quorum-sensing systems in Staphylococci as therapeutic targets, Anal. Bioanal. Chem., 387, 437, 10.1007/s00216-006-0860-0 · DOI · Paper page
  62. Gordon, 2016, Truncated Autoinducing Peptides as Antagonists of Staphylococcus lugdunensis Quorum Sensing, J. Med. Chem., 59, 8879, 10.1021/acs.jmedchem.6b00727 · DOI · Paper page
  63. Novick, 1993, Synthesis of Staphylococcal Virulence Factors is Controlled by a Regulatory RNA Molecule, Embo J., 12, 3967, 10.1002/j.1460-2075.1993.tb06074.x · DOI · Paper page
  64. Cheung, 2011, Role of the Accessory Gene Regulator Agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis, Infect. Immun., 79, 1927, 10.1128/IAI.00046-11 · DOI · Paper page
  65. Le, 2019, Role of Phenol-Soluble Modulins in Staphylococcus epidermidis Biofilm Formation and Infection of Indwelling Medical Devices, J. Mol. Biol., 431, 3015, 10.1016/j.jmb.2019.03.030 · DOI · Paper page
  66. Boles, B.R., and Horswill, A.R. (2008). Agr-Mediated Dispersal of Staphylococcus aureus Biofilms. PLoS Pathog., 4. · DOI · Paper page
  67. Lister, 2014, Staphylococcus aureus biofilms: Recent developments in biofilm dispersal, Front. Cell. Infect. Microbiol., 4, 178, 10.3389/fcimb.2014.00178 · DOI · Paper page
  68. Giraudo, 1999, The Sae Locus of Staphylococcus aureus Encodes a Two-Component Regulatory System, Fems Microbiol. Lett., 180, 117
  69. Olson, 2013, Staphylococcus aureus Nuclease is an SaeRS-Dependent Virulence Factor, Infect. Immun., 81, 1316, 10.1128/IAI.01242-12 · DOI · Paper page
  70. Xiong, 2006, Regulation of Staphylococcus aureus Alpha-Toxin Gene (Hla) Expression by Agr, sarA, and Sae in vitro and in Experimental Infective Endocarditis, J. Infect. Dis., 194, 1267, 10.1086/508210 · DOI · Paper page
  71. Liang, 2006, Inactivation of a Two-Component Signal Transduction System, SaeRS, Eliminates Adherence and Attenuates Virulence of Staphylococcus aureus, Infect. Immun., 74, 4655, 10.1128/IAI.00322-06 · DOI · Paper page
  72. Rogasch, 2006, Influence of the Two-Component System SaeRS on Global Gene Expression in Two Different Staphylococcus aureus Strains, J. Bacteriol., 188, 7742, 10.1128/JB.00555-06 · DOI · Paper page
  73. Flack, 2014, Differential regulation of staphylococcal virulence by the sensor kinase SaeS in response to neutrophil-derived stimuli, Proc. Natl. Acad. Sci. USA, 111, E2037, 10.1073/pnas.1322125111 · DOI · Paper page
  74. Sadykov, 2012, The control of death and lysis in staphylococcal biofilms: A coordination of physiological signals, Curr. Opin. Microbiol., 15, 211, 10.1016/j.mib.2011.12.010 · DOI · Paper page
  75. Rice, 2003, The Staphylococcus aureus cidAB Operon: Evaluation of Its Role in Regulation of Murein Hydrolase Activity and Penicillin Tolerance, J. Bacteriol., 185, 2635, 10.1128/JB.185.8.2635-2643.2003 · DOI · Paper page
  76. Groicher, 2000, The Staphylococcus aureus lrgAB Operon Modulates Murein Hydro-lase Activity and Penicillin Tolerance, J. Bacteriol., 182, 1794, 10.1128/JB.182.7.1794-1801.2000 · DOI · Paper page
  77. Ranjit, 2011, Staphylococcus aureus CidA and LrgA Proteins Exhibit Holin-Like Properties, J. Bacteriol., 193, 2468, 10.1128/JB.01545-10 · DOI · Paper page
  78. Brunskill, 1996, Identification and Molecular Characterization of a Putative Regulatory Locus that Affects Autolysis in Staphylococcus aureus, J. Bacteriol., 178, 611, 10.1128/jb.178.3.611-618.1996 · DOI · Paper page
  79. Schmidt, 2003, SarT influences sarS expression in Staphylococcus aureus, Infect. Immun., 71, 5139, 10.1128/IAI.71.9.5139-5148.2003 · DOI · Paper page
  80. Heinrichs, 1996, Characterization of the sar locus and its interaction with agr in Staphylococcus aureus, J. Bacteriol., 178, 418, 10.1128/jb.178.2.418-423.1996 · DOI · Paper page
  81. Zielinska, 2012, SarA-mediated Repression of Protease Production Plays a Key Role in the Pathogenesis of Staphylococcus aureus USA300 Isolates, Mol. Microbiol., 86, 1183, 10.1111/mmi.12048 · DOI · Paper page
  82. McNamara, 2000, Identification, Cloning, and Initial Characterization of rot, a Locus Encoding a Regulator of Virulence Factor Expression in Staphylococcus aureus, J. Bacteriol., 182, 3197, 10.1128/JB.182.11.3197-3203.2000 · DOI · Paper page
  83. Dunman, 2003, Global Regulation of Staphylococcus aureus Genes by Rot, J. Bacteriol., 185, 610, 10.1128/JB.185.2.610-619.2003 · DOI · Paper page
  84. Tuffs, 2019, Regulation of Toxic Shock Syndrome Toxin-1 by the Accessory Gene Regulator in Staphylococcus aureus is Mediated by the Repressor of Toxins, Mol. Microbiol., 112, 1163, 10.1111/mmi.14353 · doi:10.1111/mmi.14353
  85. Geisinger, 2006, Inhibition of rot translation by RNAIII, a key feature of agr function, Mol. Microbiol., 61, 1038, 10.1111/j.1365-2958.2006.05292.x · DOI · Paper page
  86. Boisset, 2007, Staphylococcus aureus RNAIII coordinately represses the synthesis of virulence factors and the transcription regulator Rot by an antisense mechanism, Genes Dev., 21, 1353, 10.1101/gad.423507 · DOI · Paper page
  87. Crosby, H., Schlievert, P., Merriman, J.A., King, J.M., Salgado-Pabon, W., and Horswill, A.R. (2016). The Staphylococcus aureus Global Regulator MgrA Modulates Clumping and Virulence by Controlling Surface Protein Expression. PLoS Pathog., 12. · DOI · Paper page
  88. Jonas, 2006, The sigma(B) Regulon in Staphylococcus aureus and its Regulation, Int. J. Med. Microbiol., 296, 237, 10.1016/j.ijmm.2005.11.011 · DOI · Paper page
  89. Atwood, 2015, Comparative impact of diverse regulatory loci on Staphylococcus aureus biofilm formation, MicrobiologyOpen, 4, 436, 10.1002/mbo3.250 · DOI · Paper page
  90. Kullik, 1998, Deletion of the Alternative Sigma Factor sigma(B) in Staphylococcus aureus Reveals its Function as a Global Regulator of Virulence Genes, J. Bacteriol., 180, 4814, 10.1128/JB.180.18.4814-4820.1998 · DOI · Paper page
  91. Donegan, 2009, Regulation of the mazEF Toxin-Antitoxin Module in Staphylococcus aureus and Its Impact on sigB Expression, J. Bacteriol., 191, 2795, 10.1128/JB.01713-08 · DOI
  92. Bischoff, 2004, Microar-ray-Based Analysis of the Staphylococcus aureus sigma(B) Regulon, J. Bacteriol., 186, 4085, 10.1128/JB.186.13.4085-4099.2004 · DOI · Paper page
  93. Nair, 2003, The sigma(B) Regulon Influences Internalization of Staphylococcus aureus by Osteoblasts, Infect. Immun., 71, 4167, 10.1128/IAI.71.7.4167-4170.2003 · DOI
  94. Bischoff, 2001, Influence of a Functional sigB Operon on the Global Regulators sar and agr in Staphylococcus aureus, J. Bacteriol., 183, 4079, 10.1128/JB.183.17.5171-5179.2001 · DOI · Paper page
  95. Horsburgh, 2002, Sigma(B) Modulates Virulence Determinant Expression and Stress Resistance: Characterization of a Functional rsbU Strain Derivedfrom Staphylococcus aureus 8325–4, J. Bacteriol., 184, 5457, 10.1128/JB.184.19.5457-5467.2002 · DOI · Paper page
  96. Geiger, 2008, The Virulence Regulator Sae of Staphylococcus aureus: Promoter Activities and Response to Phagocytosis-Related Signals, J. Bacteriol., 190, 3419, 10.1128/JB.01927-07 · DOI · Paper page
  97. Stenz, 2011, The CodY pleiotropic repressor controls virulence in gram-positive pathogens, FEMS Immunol. Med. Microbiol., 62, 123, 10.1111/j.1574-695X.2011.00812.x · DOI · Paper page
  98. Pohl, 2009, CodY in Staphylococcus aureus: A Regulatory Link between Metabolism and Virulence Gene Expression, J. Bacteriol., 191, 2953, 10.1128/JB.01492-08 · DOI · Paper page
  99. Majerczyk, 2010, Direct Targets of CodY in Staphylococcus aureus, J. Bacteriol., 192, 2861, 10.1128/JB.00220-10 · DOI · Paper page
  100. Waters, 2016, A Spectrum of CodY Activities Drives Metabolic Reorganization and Virulence Gene Expression in Staphylococcus aureus, Mol. Microbiol., 101, 495, 10.1111/mmi.13404 · DOI · Paper page
  101. Majerczyk, 2008, Staphylococcus aureus CodY Nega-tively Regulates Virulence Gene Expression, J. Bacteriol., 190, 2257, 10.1128/JB.01545-07 · DOI · Paper page
  102. Roy, 2018, Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action, Virulence, 9, 522, 10.1080/21505594.2017.1313372 · DOI · Paper page
  103. Otto, 2018, Staphylococcal Biofilms, Microbiol. Spectr., 6, 10, 10.1128/microbiolspec.GPP3-0023-2018 · DOI · Paper page
  104. Verma, 2019, Genomic plasticity associated with antimicrobial resistance inVibrio cholerae, Proc. Natl. Acad. Sci. USA, 116, 6226, 10.1073/pnas.1900141116 · doi:10.1073/pnas.1900141116
  105. Hoiby, 2001, Pseudomonas aeruginosa and the in vitro and in vivo Biofilm Mode of Growth, Microbes Infect., 3, 23, 10.1016/S1286-4579(00)01349-6 · DOI · Paper page
  106. Bassetti, 2018, How to manage Pseudomonas aeruginosa infections, Drugs Context, 7, 212527, 10.7573/dic.212527 · DOI · Paper page
  107. Cramton, 1999, The Intercellular Adhesion (Ica) Locus is Present in Staphylococcus aureus and is Required for Biofilm Formation, Infect. Immun., 67, 5427, 10.1128/IAI.67.10.5427-5433.1999 · DOI · Paper page
  108. Gotz, 2002, Staphylococcus and Biofilms, Mol. Microbiol., 43, 1367, 10.1046/j.1365-2958.2002.02827.x · DOI · Paper page
  109. Donlan, 2000, Role of Biofilms in Antimicrobial Resistance, Asaio J., 46, S47, 10.1097/00002480-200011000-00037 · DOI · Paper page
  110. Ou, 2020, Prevalence of Multidrug-Resistant Staphylococcus aureus Isolates with Strong Biofilm Formation Ability Among Animal-Based Food in Shanghai, Food Control., 112, 107106, 10.1016/j.foodcont.2020.107106 · DOI
  111. Costerton, 1999, Bacterial Biofilms: A Common Cause of Persistent Infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  112. Bjarnsholt, 2009, Pseudomonas aeruginosa Biofilms in the Respiratory Tract of Cystic Fibrosis Patients, Pediatr. Pulm., 44, 547, 10.1002/ppul.21011 · DOI · Paper page
  113. Miyaue, 2018, Bacterial Memory of Persisters: Bacterial Persister Cells Can Retain Their Phenotype for Days or Weeks After Withdrawal from Colony–Biofilm Culture, Front. Microbiol., 9, 1396, 10.3389/fmicb.2018.01396 · DOI · Paper page
  114. Wood, 2017, Strategies for combating persister cell and biofilm infections, Microb. Biotechnol., 10, 1054, 10.1111/1751-7915.12774 · DOI
  115. Conlon, 2014, Persister Cells in Biofilm Associated Infections, Advances in Experimental Medicine and Biology, Volume 831, 1
  116. Anderl, 2003, Role of Nutrient Limitation and Stationary-Phase Existence in Klebsiella Pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin, Antimicrob. Agents Chemother., 47, 1251, 10.1128/AAC.47.4.1251-1256.2003 · DOI · Paper page
  117. Brown, 1988, Resistance of bacterial biofilms to antibiotics a growth-rate related effect?, J. Antimicrob. Chemother., 22, 777, 10.1093/jac/22.6.777 · DOI · Paper page
  118. Waters, E., Rowe, S.E., O’Gara, J.P., and Conlon, B.P. (2016). Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells?. PLoS Pathog., 12. · DOI · Paper page
  119. Ma, 2012, Non-invasive determination of conjugative transfer of plasmids bearing antibiotic-resistance genes in biofilm-bound bacteria: Effects of substrate loading and antibiotic selection, Appl. Microbiol. Biotechnol., 97, 317, 10.1007/s00253-012-4179-9 · DOI · Paper page
  120. Kim, 2016, Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia, Microb. Drug Resist., 22, 538, 10.1089/mdr.2015.0262 · DOI
  121. Kussmann, 2018, Emergence of a Dalbavancin Induced Glycopep-tide/Lipoglycopeptide Non-Susceptible Staphylococcus aureus During Treatment of a Cardiac Device-Related Endocarditis, Emerg. Microbes Infec., 7, 202, 10.1038/s41426-018-0205-z · DOI
  122. Schwerdt, 2018, Staphylococcus aureus in the airways of cystic fibrosis patients—A retrospective long-term study, Int. J. Med. Microbiol., 308, 631, 10.1016/j.ijmm.2018.02.003 · DOI
  123. VonEiff, 1997, Recovery of Small Colony Variants of Staphylococcus aureus Following Gentamicin Bead Placement for Osteomyelitis, Clin. Infect. Dis., 25, 1250, 10.1086/516962 · DOI · Paper page
  124. Besier, 2007, Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease, J. Clin. Microbiol., 45, 168, 10.1128/JCM.01510-06 · DOI · Paper page
  125. Kahl, 2003, Thymidine-Dependent Small-Colony Variants of Staphylococcus aureus Exhibit Gross Morphological and Ultrastructural Changes Consistent with Impaired Cell Separation, J. Clin. Microbiol., 41, 410, 10.1128/JCM.41.1.410-413.2003 · DOI · Paper page
  126. Kahl, 1998, Persistent Infection with Small Colony Variant Strains of Staphylococcus aureus in Patients with Cystic Fibrosis, J. Infect. Dis., 177, 1023, 10.1086/515238 · DOI · Paper page
  127. Leimer, 2016, Nonstable Staphylococcus aureus Small-Colony Variants are Induced by Low pH and Sensitized to Antimicrobial Therapy by Phagolysosomal Alkalinization, J. Infect. Dis., 213, 305, 10.1093/infdis/jiv388 · DOI · Paper page
  128. Tuchscherr, 2020, Persistence of Staphylococcus aureus: Multiple Metabolic Pathways Impact the Expression of Virulence Factors in Small-Colony Variants (SCVs), Front. Microbiol., 11, 1028, 10.3389/fmicb.2020.01028 · DOI · Paper page
  129. Sendi, 2009, Staphylococcus aureus as an intracellular pathogen: The role of small colony variants, Trends Microbiol., 17, 54, 10.1016/j.tim.2008.11.004 · DOI · Paper page
  130. Proctor, 2019, Respiration and Small Colony Variants of Staphylococcus aureus, Microbiol. Spectr., 7, 22, 10.1128/microbiolspec.GPP3-0069-2019 · DOI · Paper page
  131. Oun, 2013, The CshA DEAD-box RNA helicase is important for quorum sensing control in Staphylococcus aureus, RNA Biol., 10, 157, 10.4161/rna.22899 · doi:10.4161/rna.22899
  132. Roux, 2011, Characterization of Components of the Staphylococcus aureus mRNA Degradosome Holoenzyme-Like Complex, J. Bacteriol., 193, 5520, 10.1128/JB.05485-11 · DOI
  133. Tuchscherr, L., Bischoff, M., Lattar, S.M., Noto Llana, M., Pförtner, H., Niemann, S., Geraci, J., Van De Vyver, H., Fraunholz, M.J., and Cheung, A.L. (2015). Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections. PLoS Pathog., 11. · DOI · Paper page
  134. Deora, 1997, Alternative transcription factor sigmaSB of Staphylococcus aureus: Characterization and role in transcription of the global regulatory locus sar, J. Bacteriol., 179, 6355, 10.1128/jb.179.20.6355-6359.1997 · DOI · Paper page
  135. Cheung, 2002, Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family, Front. Biosci. Landmark, 7, D1825, 10.2741/cheung · DOI
  136. Kim, 2007, Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran, Cell, 130, 906, 10.1016/j.cell.2007.08.002 · DOI · Paper page
  137. Samuelsen, 2005, Staphylococcus aureus Small Colony Variants are Resistant to the Antimicrobial Peptide Lactoferricin B, J. Antimicrob. Chemoth., 56, 1126, 10.1093/jac/dki385 · DOI · Paper page
  138. Werth, N., Beerlage, C., Rosenberger, C., Yazdi, A.S., Edelmann, M., Amr, A., Bernhardt, W., Von Eiff, C., Becker, K., and Schäfer, A. (2010). Activation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens. PLoS ONE, 5. · DOI · Paper page
  139. Tuchscherr, 2011, Staphylococcus aureus phenotype switching: An effective bacterial strategy to escape host immune response and establish a chronic infection, EMBO Mol. Med., 3, 129, 10.1002/emmm.201000115 · DOI · Paper page
  140. Arts, 2016, Immunometabolic circuits in trained immunity, Semin. Immunol., 28, 425, 10.1016/j.smim.2016.09.002 · DOI · Paper page
  141. Lung, 2020, Staphylococcus aureus small colony variants impair host immunity by activating host cell glycolysis and inducing necroptosis, Nat. Microbiol., 5, 141, 10.1038/s41564-019-0597-0 · DOI · Paper page
  142. Lechner, 2012, Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics, J. Mol. Microbiol. Biotechnol., 22, 235
  143. Proctor, 1996, Staphylococcus aureus Small Colony Variants Cause Persistent and Resistant Infections, Chemotherapy, 42, 47, 10.1159/000239502 · DOI
  144. Melter, 2010, Small colony variants of Staphylococcus aureus—Review, Folia. Microbiol., 55, 548, 10.1007/s12223-010-0089-3 · DOI
  145. McNamara, 2000, Staphylococcus aureus small colony variants, electron transport and persistent infections, Int. J. Antimicrob. Agents, 14, 117, 10.1016/S0924-8579(99)00170-3 · DOI
  146. Darouiche, 1994, Antibiotic penetration of and bactericidal activity within endothelial cells, Antimicrob. Agents Chemother., 38, 1059, 10.1128/AAC.38.5.1059 · DOI
  147. Mishra, 2020, Natural Anti-Biofilm Agents: Strategies to Control Biofilm-Forming Pathogens, Front. Microbiol., 11, 566325, 10.3389/fmicb.2020.566325 · DOI · Paper page
  148. An, 2021, An Overview of Biological and Computational Methods for Designing Mechanism-InforMed. Anti-biofilm Agents, Front. Microbiol., 12, 640787, 10.3389/fmicb.2021.640787 · DOI
  149. Bazzaz, 2020, The role of nanotechnology in combating biofilm-based antibiotic resistance, J. Drug Deliv. Sci. Technol., 60, 101880, 10.1016/j.jddst.2020.101880 · DOI

Cited by

See all 120

Metadata

Authors
Guo, H., Tong, Y., Cheng, J., Abbas, Z., Li, Z., Wang, J., Zhou, Y., Si, D., & Zhang, R.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-01-22
Volume
23
Issue
3
Pages
1241
ISSN
1422-0067
Cited by
120
References
14
Language
en
Funders
  • National Natural Science Foundation of China (NSFC, 31572442)
  • National Key Research and Development Program of China (2018YFD0500600)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biofilm and Small Colony Variants—An Update on Staphylococcus aureus Strategies toward Drug Resistance. https://app.cochat.ai/papers/10.3390/ijms23031241
The paper
Guo, H., Tong, Y., Cheng, J., Abbas, Z., Li, Z., Wang, J., Zhou, Y., Si, D., & Zhang, R. (2022). Biofilm and Small Colony Variants—An Update on Staphylococcus aureus Strategies toward Drug Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23031241

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.